In its September issue, Pharmaceutical Commerce details the previous and expected contributions of biologic products to its forecast of cold-chain market growth predicting sales of cold-chain drugs and biologics will outpace overall industry growth through 2022. It is reported that “as of 2018, global...
Wednesday, September 12, 2018 | Read More
In a recent news release the FDA described research it has conducted regarding detection of protein carbonylation, an oxidative reaction that may occur in therapeutic protein drug products during manufacture, storage, use, and transport potentially causing structural alterations and threatening stability,...
Tuesday, September 11, 2018 | Read More
Sentry BioPharma Services is pleased to announce delegates from Sentry’s Business Development team will be in New York City attending the Drug, Chemical & Associated Technologies Association (DCAT) Week March 19th -22nd. The four-day conference brings together key sourcing, procurement and business...
Monday, March 19, 2018 | Read More
Biotech and pharmaceutical companies leverage Sentry's contract pharmaceutical manufacturing background and a versatile network of pharmaceutical cold chain logistics providers to successfully plan, source, make and deliver temperature-sensitive products. Sentry adheres to the Supply-Chain Council's Supply Chain Operations Reference (SCOR®) model. The model provides a framework linking processes, metrics, best practices and technology into a unified structure to support supply chain communication and improve management effectiveness. Planning, sourcing, making, delivering and returning processes comprise the foundation of the SCOR® model.
Sentry's core functions extend to all pharmaceutical supply chain interdependencies. This unified, cohesive approach integrates manufacturers, researchers, distributors, software systems, consultants and channel supply partners to meet emerging customer expectations.
From early-phase shipper and channel qualification to supporting cost-effective commercial product launches, Sentry utilizes biopharma experience and relationships with qualified vendors, brokers and manufacturers to design and implement domestic and international pharmaceutical supply chain solutions.
Sentry's Supply Chain Programs
Sentry anticipates, understands and addresses regulatory expectations and best practices, ensuring product integrity in every phase of the pharmaceutical supply chain. With 24/7 online data access, clients can monitor inventory and tracking information in real time for total transparency.
For more information about how Sentry's supply chain management programs can ensure product integrity in every phase of the pharmaceutical supply chain, contact Sentry via email or by phone at 1-866-757-7400.